Kinesia technology provides a standardized platform to quantify Parkinson's disease symptoms in the clinic and at home. The Kinesia patient kit and web application provide continuous remote symptom monitoring and reporting. Applications include patient care, telemedicine, clinical trials, and deep brain stimulation programming.
We have partnered with world-renowned movement disorder centers and neurologists to conduct clinical studies validating Kinesia automated scoring algorithms to quantify tremor, measure bradykinesia, and assess dyskinesia. Hundreds of individuals with Parkinson's disease have successfully used Kinesia for assessing movement disorders in both clinical and home environments.
We are very excited to announce our Kinesia ProView™ product launch. The press release details our plans to change the face of DBS programming. Our 2013 Webinar Series targeting Technology in Parkinson's Clinical Trials begins next month. [Read More] In January we launched a new study to develop intelligent algorithms for assisting with programming deep brain stimulation in Parkinson's patients. [Read the Press Release]